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Johnston and Cutler, page 774
Recombination hotspots are defined as genomic areas that
undergo higher rates of recombination than do their
surrounding areas. But what, at a molecular level, defines
these hotspots, and how prevalent are they in the human
genome? Many investigators point to a key role for
PRDM9 binding in dictating the location of hotspots.
Taking an alternative view, Johnston and Cutler examine
the idea that human demographic history has distorted
most analyses of hotspots. Whereas most models assume
a constant effective population size over time, the authors
posit that because older regions of the genome have
undergone a greater number of total recombination
events, they might appear to experience a higher rate of
recombination. To address this possibility, they generated
a model wherein recombination rates are constant but
population sizes change. Their analysis shows that popu-
lation bottlenecks alone can create the appearance of
hotspots. Although the debate is far from over, this report
should prompt researchers to more carefully analyze
claims of hotspot discoveries.A Genetic Brain Booster?
Ameur et al., page 809
Long-chain polyunsaturated fatty acids (LC-PUFAs) are
essential for brain function. Although LC-PUFAs can be
obtained from food, they are also synthesized from
precursor molecules. Recent research has identified the
enzymes—FADS1 and FADS2—that direct this synthesis,
and interestingly, the genes that encode these proteins
are positioned in a head-to-head orientation on chromo-
some 11. Therefore, it is possible that common regulatory
mechanisms might be at play. In this issue, Ameur et al.
take this idea further and show that two common
haplotypes are associated with LC-PUFA biosynthesis.
Strikingly, the haplotype associated with more efficient
biosynthesis shows a signature of having undergone
positive selection. Given the importance of LC-PUFAs
for the brain, the authors postulate that this haplotype
might have been beneficial for early humans in terms of
promoting brain-size expansion, especially during periods
in which fatty acids were scarce. This potential benefit,1Deputy Editor, AJHG
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acid metabolism in the setting of a Western diet presents
the risk of numerous health issues, including coronary
heart disease. Might apparent ethnic differences in so-
called lifestyle diseases be attributable to different haplo-
types? The authors suggest that this might indeed be
the case; genotyping to determine one’s FADS haplotype
could therefore be helpful in generating dietary recom-
mendations.NO to the Rescue
Nagamani et al., page 836
Argininosuccinic aciduria (ASA), an inborn error of metab-
olism, results from the lack of a key metabolic enzyme,
argininosuccinate lyase (ASL). ASL is the only enzyme
that can generate L-arginine, a precursor required for the
proper function of several metabolic pathways. Affected
individuals display hyperammonemia as well as several
other defects, e.g., neurocognitive deficits and hyper-
tension. Notably, although the standard treatment of
L-arginine supplementation can prevent the hyperammo-
nemia, longer-term defects, including hypertension,
persist. In this issue, Nagamani et al. reason that supple-
mentation with NO, a critical metabolite whose produc-
tion relies on ASL function, might help to correct these
‘‘secondary’’ defects. Indeed, this treatment regimen was
able to reverse a severe case of hypertension in an indi-
vidual harboring compound heterozygous mutations in
ASL. Moreover, the authors’ findings also suggest that
NO can improve neurocognitive function. Although this
is a preliminary study of one individual, the marked
improvement that was observed, in conjunction with
the authors’ gene-therapy studies in mice, suggests that
NO supplementation has great promise in treating ASA.
Indeed, this study provides a compelling example of
what the future of personalized medicine might hold in
store.More Clues in the ASD Mystery
Sato et al., page 879
Autism spectrum disorder (ASD) is in the news a lot these
days. Earlier this month, the US Centers for Disease
Control reported that an estimated 1 in 88 children isGenetics. All rights reserved.
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affected. Although we now have a better handle on diag-
nosing ASD, the causes remain as elusive as ever. Many
studies have pointed to potential roles for environmental
factors, and there is much evidence to support a causative
role of de novo mutations. However, it is clear that in-
herited mutations are also involved. In this issue, Sato
et al. identify mutations—both inherited and de novo—
that result in the deletion of SHANK1 in individuals with
ASD. Interestingly, thesemutations appear to have reduced
penetrance in females, perhaps providing some clues
about the well-described male gender bias. SHANK1 joins
its family members, SHANK2 and SHANK3, all of which
encode neuronal scaffolding proteins, as being implicated
in ASD etiology. Future experiments should help to
uncover the exact role played by these proteins in the
brain, perhaps shedding some light on why their absence
can lead to ASD. Also, the authors identify additional
mutations that, in conjunction with SHANK1 deletions,
probably contribute to their ASD phenotypes. The way in
which interplay between mutations, along with gene-
environment interactions, influences ASD is poorly under-
stood, and much more research on this topic is needed.
Indeed, although many pieces of the puzzle have been re-
vealed, how they all fit together is still far from clear.756 The American Journal of Human Genetics 90, 755–756, May 4, 2Ice Age Hiding Places
Pala et al., page 915
Throughout their history, human populations have faced
numerous external stressors that caused population
contractions. During such periods, humans are thought
to have formed small groups in isolated geographic loca-
tions, or refugia. Once conditions improve, population
expansions ensue, and movement out of the refugia into
new territories follows. During the last ice age, humans
sought refuge throughout Europe and the Near East (an
area roughly equivalent to the present-day Middle East),
but there is a lack of certainty regarding the dispersal
patterns during the Late Glacial period. In this issue, Pala
et al. analyze hundreds of new mtDNA sequences to
show that humans moved from the Near East into Europe
at this time. Prior to this report, most models posited that
such movement did not occur until ~10,000 years later.
However, these new findings suggest that such models
should be re-examined because the previously detected
signatures of Neolithic expansion might instead represent
indigenous European dispersals. Although we will never
know exactly what paths our ancestors took, findings
such as this one help to paint a much clearer picture.012
